WO2022262245A1 - Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicament - Google Patents
Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicament Download PDFInfo
- Publication number
- WO2022262245A1 WO2022262245A1 PCT/CN2021/141051 CN2021141051W WO2022262245A1 WO 2022262245 A1 WO2022262245 A1 WO 2022262245A1 CN 2021141051 W CN2021141051 W CN 2021141051W WO 2022262245 A1 WO2022262245 A1 WO 2022262245A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aflatoxin
- sample
- column
- detection
- solution
- Prior art date
Links
- 229930195730 Aflatoxin Natural products 0.000 title claims abstract description 86
- 239000005409 aflatoxin Substances 0.000 title claims abstract description 86
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 39
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000012085 test solution Substances 0.000 claims abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 35
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 28
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 20
- 239000003643 water by type Substances 0.000 claims description 15
- 235000019766 L-Lysine Nutrition 0.000 claims description 14
- 239000004472 Lysine Substances 0.000 claims description 14
- 238000004949 mass spectrometry Methods 0.000 claims description 13
- WWSYXEZEXMQWHT-WNWIJWBNSA-N aflatoxin B2 Chemical compound C=1([C@@H]2CCO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O WWSYXEZEXMQWHT-WNWIJWBNSA-N 0.000 claims description 11
- 229930132918 Aflatoxin B2 Natural products 0.000 claims description 10
- 229930063498 Aflatoxin G1 Natural products 0.000 claims description 10
- XWIYFDMXXLINPU-WNWIJWBNSA-N Aflatoxin G1 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1C=CO[C@@H]1O2 XWIYFDMXXLINPU-WNWIJWBNSA-N 0.000 claims description 10
- WPCVRWVBBXIRMA-WNWIJWBNSA-N Aflatoxin G2 Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1[C@@H]1CCO[C@@H]1O2 WPCVRWVBBXIRMA-WNWIJWBNSA-N 0.000 claims description 10
- 108010024636 Glutathione Proteins 0.000 claims description 10
- 239000002115 aflatoxin B1 Substances 0.000 claims description 10
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 claims description 10
- 239000002097 aflatoxin B2 Substances 0.000 claims description 10
- 239000002098 aflatoxin G1 Substances 0.000 claims description 10
- 229930020125 aflatoxin-B1 Natural products 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 229960003180 glutathione Drugs 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229930166256 Aflatoxin G2 Natural products 0.000 claims description 9
- 239000002100 aflatoxin G2 Substances 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical group O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 claims description 6
- 229960002632 acarbose Drugs 0.000 claims description 6
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 6
- 229960001570 ademetionine Drugs 0.000 claims description 4
- VERAMNDAEAQRGS-UHFFFAOYSA-N butane-1,4-disulfonic acid Chemical compound OS(=O)(=O)CCCCS(O)(=O)=O VERAMNDAEAQRGS-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 238000001195 ultra high performance liquid chromatography Methods 0.000 claims description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 claims description 2
- 229960003646 lysine Drugs 0.000 claims description 2
- 238000002552 multiple reaction monitoring Methods 0.000 claims description 2
- 238000005173 quadrupole mass spectroscopy Methods 0.000 claims description 2
- 150000001343 alkyl silanes Chemical group 0.000 claims 1
- 238000001819 mass spectrum Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 47
- 239000011159 matrix material Substances 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 238000011002 quantification Methods 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 2
- 238000000861 blow drying Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 49
- 239000012488 sample solution Substances 0.000 description 15
- 239000003085 diluting agent Substances 0.000 description 13
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- DMNNAGLOODQTOQ-HXTWIPGBSA-N [C@@H]1([C@H](O)[C@H](O)[C@@H](CN[C@@H](CCSC)C(=O)O)O1)N1C=NC=2C(N)=NC=NC12.C(CCCS(=O)(=O)O)S(=O)(=O)O Chemical compound [C@@H]1([C@H](O)[C@H](O)[C@@H](CN[C@@H](CCSC)C(=O)O)O1)N1C=NC=2C(N)=NC=NC12.C(CCCS(=O)(=O)O)S(=O)(=O)O DMNNAGLOODQTOQ-HXTWIPGBSA-N 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 7
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 7
- 238000012417 linear regression Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 241000228197 Aspergillus flavus Species 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012087 reference standard solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228230 Aspergillus parasiticus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/52—Physical parameters
- G01N30/54—Temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
Definitions
- the purpose of the present invention is to provide a method for detecting trace amounts of aflatoxin in water-soluble fermented medicines.
- the method has the advantages of high selectivity and high sensitivity, simple sample pretreatment, no interference of the sample matrix to the determination of the target peak, and good durability of the method.
- the specific scheme is as follows:
- Acarbose sample solution Weigh 400mg of acarbose sample into a 15mL centrifuge tube, accurately add 1.0mL ultrapure water for ultrasonic dissolution for 5min, then precisely add 2.0mL of dichloromethane, mix well, let stand for 2min, discard
- 1.0 mL of the lower layer solution was precisely pipetted into a sample injection vial, blown dry with nitrogen, then added 1.0 mL of diluent to dissolve, shake well, and serve as the test solution.
- the above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxin was not detected in the acarbose sample solution, which was less than the detection limit (0.045 ⁇ g/kg).
- L-lysine sample solution Weigh 30mg of L-lysine sample into a 15mL centrifuge tube, add 1.0mL water to ultrasonically dissolve for 5min, then add 2.0mL dichloromethane, mix well, let stand for 2min, discard the upper solution , Pipette 1.0mL of the lower layer solution into the sample injection vial, dry it with nitrogen, then add 1.0mL of diluent to dissolve, shake well, and use it as the test solution.
- the above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxins were not detected in the L-lysine sample solution, which was less than the detection limit (0.06 ⁇ g/kg).
- 1,4-butanedisulfonic acid adenosylmethionine sample solution Weigh 600mg of 1,4-butanedisulfonic acid adenosylmethionine sample into a 15mL centrifuge tube, add 1.0mL water for ultrasonic dissolution for 5min, then add 2.0mL dichloromethane , mix well, let it stand for 2min, discard the upper layer solution, pipette 1.0mL of the lower layer solution into the injection vial, blow dry with nitrogen, then add 1.0mL diluent to dissolve, shake well, and use it as the test solution.
Abstract
A method for analyzing and detecting trace aflatoxin in a water-soluble fermented medicament. The method comprises: (1) extracting an aqueous solution of a sample with dichloromethane, blow-drying same with nitrogen, and then dissolving same with a 30% aqueous solution (V/V) of methanol to obtain a test solution; and (2) performing detection by means of ultra-high performance liquid chromatography-mass spectrometry. The problems of a matrix interfering with the determination of a target peak and residual samples in an instrument causing the contamination of the instrument are solved by means of extraction. Aflatoxin and a sample can be fully and effectively separated within 7 min, the linearly dependent coefficient r of aflatoxin in respective linear ranges is more than 0.99, the lowest limit of quantification is 3 ng/L, the lowest limit of detection is 1 ng/L, and the average spiked recovery rate is 80%-120%. The detection method has the characteristics of high speed, high efficiency, high sensitivity, no matrix interference in sample detection, good durability, etc., and can be suitable for quantitative and qualitative detection of aflatoxin in a water-soluble medicament.
Description
本发明涉及医药技术领域,更具体的说,是涉及水溶性发酵药物中微量黄曲霉毒素分析检测方法The invention relates to the technical field of medicine, more specifically, to a method for analyzing and detecting trace amounts of aflatoxins in water-soluble fermented medicines
黄曲霉毒素(AFLATOXIN,简称AFT)是黄曲霉菌和寄生曲霉菌新陈代谢的产物,是公认的最强烈的一种自然致癌物。这些菌株主要寄生在食用油、玉米、大米、花生米、干果、调味品、饲料及多种食品中,并产生毒素,可引起人和畜禽的中毒。黄曲霉毒素的化学结构已确定,包含黄曲霉毒素B1(AFB1)、黄曲霉毒素B2(AFB2)、黄曲霉毒素G1(AFG1)、黄曲霉毒素G2(AFG2)等10多种,其中AFB1、AFB2、AFG1、AFG2结构如下:Aflatoxin (AFLATOXIN, referred to as AFT) is a product of the metabolism of Aspergillus flavus and Aspergillus parasiticus, and is recognized as the strongest natural carcinogen. These strains mainly parasitize in edible oil, corn, rice, peanuts, dried fruits, condiments, feed and various foods, and produce toxins, which can cause poisoning of humans and livestock. The chemical structure of aflatoxin has been determined, including more than 10 kinds of aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin G2 (AFG2), among which AFB1, AFB2 , AFG1, AFG2 structures are as follows:
发酵类药物所用的粮食类原材料含有黄曲霉菌或寄生曲霉菌寄生,可能产生黄曲霉毒素,各国药典要求限度控制在2μg/kg以下。黄曲霉毒素检测方法有薄层色谱法(TIC)、液相色谱法(HPLC)、酶联免疫法(ELISA)、荧光光度法(IAC/SFB)、 超高效液相-质谱法(UPLC-MS)等,这些方法检测灵敏度较高(mg/kg级),样品前处理方法繁琐,样品中基质干扰黄曲霉毒素测定等不足点。本方法采用超高效液相色谱进行分离,高选择性与高灵敏度质谱进行检测,检测灵敏度更高(μg/kg级);样品采用溶解萃取方式,前处理简单,样品基质对目标峰测定无干扰;方法耐用性好,可以很好的检测样品中微量黄曲霉毒素的含量,以确保下游产品的产品质量。The grain raw materials used in fermented drugs contain Aspergillus flavus or Aspergillus parasitica, which may produce aflatoxin, and the pharmacopoeia of various countries requires the limit to be controlled below 2 μg/kg. Aflatoxin detection methods include thin-layer chromatography (TIC), liquid chromatography (HPLC), enzyme-linked immunoassay (ELISA), fluorescence spectrometry (IAC/SFB), ultra-performance liquid chromatography-mass spectrometry (UPLC-MS ), etc., these methods have high detection sensitivity (mg/kg level), sample pretreatment methods are cumbersome, and the matrix in the sample interferes with the aflatoxin determination and other shortcomings. This method adopts ultra-high performance liquid chromatography for separation, high selectivity and high sensitivity mass spectrometry for detection, and the detection sensitivity is higher (μg/kg level); the sample is dissolved and extracted, the pretreatment is simple, and the sample matrix does not interfere with the determination of the target peak ; The method has good durability, and can detect the content of trace aflatoxin in the sample very well, so as to ensure the product quality of downstream products.
发明内容Contents of the invention
本申请的发明人发现,发酵药物所用到的粮食类原材料中有可能被黄曲霉毒素污染,为了实现对发酵药物中微量黄曲霉毒素质量控制,需要对发酵药物中微量黄曲霉毒素进行检测。The inventors of the present application found that the grain raw materials used in fermented medicines may be contaminated by aflatoxin. In order to realize the quality control of trace aflatoxins in fermented medicines, it is necessary to detect the traces of aflatoxins in fermented medicines.
本发明的目的是提供一种水溶性发酵药物中微量黄曲霉毒素检测方法,该方法具有高选择性与高灵敏度、样品前处理简单,样品基质对目标峰测定无干扰,方法耐用性好等优点,具体方案如下:The purpose of the present invention is to provide a method for detecting trace amounts of aflatoxin in water-soluble fermented medicines. The method has the advantages of high selectivity and high sensitivity, simple sample pretreatment, no interference of the sample matrix to the determination of the target peak, and good durability of the method. , the specific scheme is as follows:
一种检测水溶性发酵药物中微量黄曲霉毒素的方法,所述黄曲霉毒素包括黄曲霉毒素B1、黄曲霉毒素B2、黄曲霉毒素G1、黄曲霉毒素G2,其特征在于,所述方法包括:A method for detecting trace amounts of aflatoxin in water-soluble fermented medicines, said aflatoxin comprising aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, characterized in that said method comprises:
步骤1:样品用水溶解后,用二氯甲烷萃取得萃取液,萃取液用氮气吹干,再用30%甲醇水溶液(V/V)溶解获得供试品溶液;Step 1: After dissolving the sample in water, extract it with dichloromethane to obtain the extract, dry the extract with nitrogen, and then dissolve it with 30% aqueous methanol (V/V) to obtain the test solution;
步骤2:采用超高效液相色谱-质谱联用仪对步骤1的供试品溶液进行检测;Step 2: using ultra-high performance liquid chromatography-mass spectrometry to detect the test solution in step 1;
其中,步骤2所述超高效液相色谱的色谱条件为:Wherein, the chromatographic condition of the ultra-high performance liquid chromatography described in step 2 is:
色谱柱:十八烷基硅烷键合硅胶色谱柱;Chromatographic column: octadecylsilane bonded silica gel column;
流动相:流动相A为10mM甲酸铵水溶液,流动相B为甲醇;流动相的梯度洗脱方式为梯度洗脱,所述梯度洗脱的程序如下表:Mobile phase: Mobile phase A is 10mM ammonium formate aqueous solution, and mobile phase B is methanol; The gradient elution mode of mobile phase is gradient elution, and the program of described gradient elution is as follows:
时间(min)time (min) | 流动相A%Mobile phase A% | 流动相B%Mobile phase B% |
0.00.0 | 7070 | 3030 |
3.03.0 | 2020 | 8080 |
5.05.0 | 2020 | 8080 |
5.15.1 | 7070 | 3030 |
7.07.0 | 7070 | 3030 |
步骤2中所述超高效液相色谱-质谱联用仪为:超高效液相色谱-三重四级杆质谱联用仪;The ultra-high performance liquid chromatography-mass spectrometer described in step 2 is: ultra-high performance liquid chromatography-triple quadrupole mass spectrometry;
所述水溶性发酵药物选自阿卡波糖、1,4-丁二磺酸腺苷蛋氨酸、L-赖氨酸和谷胱甘肽。The water-soluble fermented medicine is selected from acarbose, 1,4-butanedisulfonic acid ademetionine, L-lysine and glutathione.
步骤1中,所述样品用水溶解后,配置成1mL中溶解1~1000mg、优选为1~800mg、更优选1~700mg、最优选10~500mg的样品溶液;加入二氯甲烷2mL,混匀,静置后弃去上层溶液,移取下层溶液1mL,氮气吹干,直接用30%甲醇水溶液(V/V)溶解,获得供试品溶液。In step 1, after the sample is dissolved in water, it is prepared to dissolve 1-1000 mg, preferably 1-800 mg, more preferably 1-700 mg, most preferably 10-500 mg of sample solution in 1 mL; add 2 mL of dichloromethane, mix well, After standing, the upper layer solution was discarded, and 1 mL of the lower layer solution was pipetted, blown dry with nitrogen, and directly dissolved with 30% methanol aqueous solution (V/V) to obtain the test solution.
步骤2中所述十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~4.6mm、柱长为50mm~150mm、粒径为1.6μm~3.5μm;优选十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~3.5mm、柱长为50mm~100mm、粒径为1.6μm~2.5μm;更优选十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~3.0mm、柱长为50mm~100mm、粒径为1.6μm~1.8μm;最优选Waters
C18色谱柱,柱径为2.1mm、柱长为100mm、粒径为1.6μm。
The octadecylsilane-bonded silica gel column described in step 2 has a column diameter of 2.1 mm to 4.6 mm, a column length of 50 mm to 150 mm, and a particle diameter of 1.6 μm to 3.5 μm; preferably octadecylsilane bonded silica gel The column diameter of the chromatographic column is 2.1 mm to 3.5 mm, the column length is 50 mm to 100 mm, and the particle size is 1.6 μm to 2.5 μm; more preferably, the column diameter of the octadecylsilane bonded silica gel column is 2.1 mm to 3.0 mm, The column length is 50mm ~ 100mm, the particle size is 1.6μm ~ 1.8μm; the most preferred Waters C18 chromatographic column, the column diameter is 2.1mm, the column length is 100mm, and the particle size is 1.6μm.
步骤2中所述色谱柱的柱温为25℃~45℃,优选30℃~45℃,更优选35℃~40℃,最优选40℃。The column temperature of the chromatographic column in step 2 is 25°C-45°C, preferably 30°C-45°C, more preferably 35°C-40°C, most preferably 40°C.
步骤2中所述流动相的流速为0.2mL/min~0.6mL/min,优选0.3mL/min~0.5mL/min,更优选0.3mL/min~0.4mL/min,最优选0.3mL/min。The flow rate of the mobile phase in step 2 is 0.2mL/min-0.6mL/min, preferably 0.3mL/min-0.5mL/min, more preferably 0.3mL/min-0.4mL/min, most preferably 0.3mL/min.
步骤2中所述质谱的参数为:The parameters of mass spectrometry described in step 2 are:
扫描模式:质谱多反应监测;Scan mode: mass spectrometry multiple reaction monitoring;
离子源:电喷雾离子源;Ion source: electrospray ion source;
离子源模式:正模式;Ion source mode: positive mode;
毛细管电压:0.3~1.0KV,优选0.4~0.8KV,更优选0.5KV;Capillary voltage: 0.3-1.0KV, preferably 0.4-0.8KV, more preferably 0.5KV;
干燥气温度:300~650℃,优选450~600℃,更优选550℃;Drying gas temperature: 300-650°C, preferably 450-600°C, more preferably 550°C;
干燥气流速:1000L/Hr;Drying gas flow rate: 1000L/Hr;
锥孔电压:15~40V,优选20~30V,更优选35V;Cone voltage: 15-40V, preferably 20-30V, more preferably 35V;
源温:150℃。Source temperature: 150°C.
步骤2中所述超高效液相色谱-质谱联用仪为Waters ACQUITY I
PLUS\XEVO TQ-XS、Waters ACQUITY I UPLC Class-TQ-S micro、Agilent 1290-6470,优选Waters ACQUITY I
PLUS\XEVO TQ-XS。
The ultra-high performance liquid chromatography-mass spectrometer described in step 2 is Waters ACQUITY I PLUS\XEVO TQ-XS, Waters ACQUITY I UPLC Class-TQ-S micro, Agilent 1290-6470, preferably Waters ACQUITY I PLUS\XEVO TQ-XS.
在本发明前述的超高效液相-质谱联用检测黄曲霉毒素方法中,超高效液相-质谱联用色谱条件如下:In the aforementioned ultra-high performance liquid phase-mass spectrometry method for detecting aflatoxins of the present invention, the ultra-high performance liquid phase-mass spectrometry chromatographic conditions are as follows:
柱温:40℃Column temperature: 40°C
流速:0.3mL/minFlow rate: 0.3mL/min
检测器选自三重四级杆质谱检测器。Detectors were selected from triple quadrupole mass detectors.
本发明提供的超高效液相-质谱联用检测微量黄曲霉毒素的方法,具有以下优点:样品前处理简单,采用样品溶解萃取方式解决了样品基质干扰目标峰测定及样品在仪器中残留引起仪器污染;分离度好,黄曲霉毒素与样品在7min实现全部有效分离;线性相关系数好,黄曲霉毒素在各自的线性范围内线性相关系数r均>0.99;灵敏度高,仪器检测最低定量限为3ng/L,最低检测限为1ng/L;回收率高,黄曲霉毒素样品加标准确度回收率均在80%~120%。本方法与现有黄曲霉毒素测定方法对比具有快速、高效、灵敏度高、样品检测无基质干扰,耐用性好等特点,可适用于水溶性药物中黄曲霉毒素定量及定性检测。The ultra-high performance liquid phase-mass spectrometry method for detecting trace aflatoxins provided by the present invention has the following advantages: the sample pretreatment is simple, and the method of sample dissolution and extraction is used to solve the problem of sample matrix interference target peak determination and sample residue in the instrument. Contamination; good separation, all effective separation of aflatoxin and sample in 7 minutes; good linear correlation coefficient, linear correlation coefficient r>0.99 of aflatoxin in their respective linear ranges; high sensitivity, the lowest quantitative limit of instrument detection is 3ng /L, the minimum detection limit is 1ng/L; the recovery rate is high, and the recovery rate of the standardization accuracy of aflatoxin samples is 80% to 120%. Compared with the existing aflatoxin determination method, the method has the characteristics of rapidity, high efficiency, high sensitivity, no matrix interference in sample detection, good durability, etc., and can be applied to the quantitative and qualitative detection of aflatoxin in water-soluble drugs.
图1为本发明方法实施例1中黄曲霉毒素(AFB1、AFB2、AFG1、AFG2)标准溶液超高效液相-质谱联用图谱。Fig. 1 is an ultra-high performance liquid chromatography-mass spectrometry spectrum of aflatoxin (AFB1, AFB2, AFG1, AFG2) standard solution in Example 1 of the method of the present invention.
图2为本发明方法实施例1中黄曲霉毒素(AFB1、AFB2、AFG1、AFG2)定量限溶液超高效液相-质谱联用图谱。Fig. 2 is an ultra-high performance liquid chromatography-mass spectrometry spectrum of aflatoxin (AFB1, AFB2, AFG1, AFG2) quantitative limit solution in Example 1 of the method of the present invention.
图3为本发明方法实施例1中黄曲霉毒素(AFB1、AFB2、AFG1、AFG2)检测限超高效液相-质谱联用图谱。3 is an ultra-high performance liquid chromatography-mass spectrometry spectrum of detection limits of aflatoxins (AFB1, AFB2, AFG1, AFG2) in Example 1 of the method of the present invention.
为使本发明的目的、技术方案及优点更加清楚明白,以下参照附图并举实施例, 对本发明进一步详细说明。In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and examples.
用黄曲霉毒素作为对照品,对水溶性发酵药物中的微量黄曲霉毒素含量进行检测如下:Using aflatoxin as a reference substance, the trace aflatoxin content in the water-soluble fermented medicine is detected as follows:
实施例1:Example 1:
色谱条件:Chromatographic conditions:
仪器:沃特世超高效液相-三重四级杆质谱联用仪(Waters ACQUITY I UPLC Class-TQ-S micro)Instrument: Waters ACQUITY I UPLC Class-TQ-S micro
流速:0.3mL/minFlow rate: 0.3mL/min
柱温:40℃Column temperature: 40°C
进样量:10.0μLInjection volume: 10.0μL
流动相A:10mM甲酸铵水溶液(称取质谱级甲酸铵0.32g,用500mL超纯水溶解,混匀)Mobile phase A: 10mM ammonium formate aqueous solution (weigh 0.32g of mass spectrometry grade ammonium formate, dissolve with 500mL ultrapure water, and mix well)
流动相B:甲醇Mobile Phase B: Methanol
稀释剂:30%甲醇水溶液(V/V)Diluent: 30% aqueous methanol (V/V)
洗针溶液:80%甲醇水溶液(V/V)Needle washing solution: 80% methanol water solution (V/V)
空白溶剂:同稀释剂Blank solvent: same as diluent
梯度:gradient:
时间(min)time (min) | 流动相A%Mobile phase A% | 流动相B%Mobile phase B% |
0.00.0 | 7070 | 3030 |
3.03.0 | 2020 | 8080 |
5.05.0 | 2020 | 8080 |
5.15.1 | 7070 | 3030 |
7.07.0 | 7070 | 3030 |
质谱条件:Mass Spectrometry Conditions:
黄曲霉毒素对照品标准溶液配制:精密移取适量黄曲霉毒素对照品储备溶液,逐级稀释配制含有黄曲霉毒素(AFB1、AFB2、AFG1、AFG2)浓度分别为30ng/L、60ng/L、120ng/L、150ng/L、250ng/L的溶液,作为标准曲线测定液。Preparation of aflatoxin reference standard solution: Precisely pipette an appropriate amount of aflatoxin reference stock solution, and dilute it step by step to prepare aflatoxin (AFB1, AFB2, AFG1, AFG2) concentrations of 30ng/L, 60ng/L, and 120ng respectively /L, 150ng/L, 250ng/L solutions, as the standard curve measurement solution.
所述实施例1中四种黄曲霉毒素的线性回归方程及线性相关系数r见表1,方程中y即为相应黄曲霉毒素的峰面积,x即为相应黄曲霉毒素的质量浓度。The linear regression equation and the linear correlation coefficient r of the four aflatoxins in Example 1 are shown in Table 1. In the equation, y is the peak area of the corresponding aflatoxin, and x is the mass concentration of the corresponding aflatoxin.
表1黄曲霉毒素在实施例1中线性回归方程、线性相关系数r、检测限及定量限。Table 1 Linear regression equation, linear correlation coefficient r, detection limit and quantification limit of aflatoxin in Example 1.
分析物Analyte | 线性范围Linear range | 线性方程linear equation | 相关系数rCorrelation coefficient r | 检测限detection limit | 定量限The limit of quantitation |
the | (ng/L)(ng/L) | the | the | (ng/L)(ng/L) | (ng/L)(ng/L) |
AFB1AFB1 | 30~25030~250 | y=36364.7536x-1102.8058y=36364.7536x-1102.8058 | 0.99970.9997 | 99 | 3030 |
AFB2AFB2 | 30~25030~250 | y=28317.6766x-238.3089y=28317.6766x-238.3089 | 0.99950.9995 | 99 | 3030 |
AFG1AFG1 | 30~25030~250 | y=33927.5089x+552.9885y=33927.5089x+552.9885 | 0.99250.9925 | 99 | 3030 |
AFG2AFG2 | 30~25030~250 | y=18460.1754x+7.3658y=18460.1754x+7.3658 | 0.99670.9967 | 99 | 3030 |
注:检测限及定量限限度=相应对照品溶液浓度/样品浓度Note: detection limit and quantitative limit = corresponding reference substance solution concentration/sample concentration
阿卡波糖原料药中黄曲霉毒素检测:Detection of Aflatoxin in Acarbose API:
阿卡波糖样品溶液:称取阿卡波糖样品400mg于15mL离心管中,精密加入1.0mL超纯水超声溶解5min,再精密加入二氯甲烷2.0mL,混匀,静置2min,弃去上层溶液,精密移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在阿卡波糖样品溶液中均未检出,即小于检测限限度(0.045μg/kg)。Acarbose sample solution: Weigh 400mg of acarbose sample into a 15mL centrifuge tube, accurately add 1.0mL ultrapure water for ultrasonic dissolution for 5min, then precisely add 2.0mL of dichloromethane, mix well, let stand for 2min, discard For the upper layer solution, 1.0 mL of the lower layer solution was precisely pipetted into a sample injection vial, blown dry with nitrogen, then added 1.0 mL of diluent to dissolve, shake well, and serve as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxin was not detected in the acarbose sample solution, which was less than the detection limit (0.045 μg/kg).
表2黄曲霉毒素在实施例1中准确度Accuracy of table 2 aflatoxin in embodiment 1
实施例2:Example 2:
仪器:沃特世超高效液相-三重四级杆质谱联用仪(Waters ACQUITY I
PLUS\XEVO TQ-XS)
Instrument: Waters ultra-high performance liquid chromatography-triple quadrupole mass spectrometer (Waters ACQUITY I PLUS\XEVO TQ-XS)
流速:0.3mL/minFlow rate: 0.3mL/min
柱温:40℃Column temperature: 40°C
进样量:10.0μLInjection volume: 10.0μL
流动相A:10mM甲酸铵水溶液(称取质谱级甲酸铵0.32g,用500mL超纯水溶解)Mobile phase A: 10mM ammonium formate aqueous solution (weigh 0.32g of mass spectrometry grade ammonium formate and dissolve in 500mL ultrapure water)
流动相B:甲醇Mobile Phase B: Methanol
稀释剂:30%甲醇水溶液(V/V)Diluent: 30% aqueous methanol (V/V)
洗针溶液:80%甲醇水溶液(V/V)Needle washing solution: 80% methanol water solution (V/V)
空白溶剂:同稀释剂Blank solvent: same as diluent
梯度:gradient:
时间(min)time (min) | 流动相A%Mobile phase A% | 流动相B%Mobile phase B% |
0.00.0 | 7070 | 3030 |
3.03.0 | 2020 | 8080 |
5.05.0 | 2020 | 8080 |
5.15.1 | 7070 | 3030 |
7.07.0 | 7070 | 3030 |
质谱条件:Mass spectrometry conditions:
黄曲霉毒素对照品标准溶液配制:精密移取适量黄曲霉毒素对照品溶液,逐级稀释配制含有黄曲霉毒素浓度分别为3ng/L、6ng/L、12ng/L、15ng/L、25ng/L的溶液,作为标准曲线测定液。Preparation of aflatoxin reference standard solution: Precisely pipette an appropriate amount of aflatoxin reference solution, and dilute it step by step to prepare aflatoxin concentrations of 3ng/L, 6ng/L, 12ng/L, 15ng/L, and 25ng/L The solution was used as the standard curve measurement solution.
所述实施例2中四种黄曲霉毒素的线性回归方程及线性相关系数r见表3,方程中y即为相应黄曲霉毒素的峰面积,x即为相应黄曲霉毒素的质量浓度。The linear regression equation and the linear correlation coefficient r of the four aflatoxins in Example 2 are shown in Table 3. In the equation, y is the peak area of the corresponding aflatoxin, and x is the mass concentration of the corresponding aflatoxin.
表3黄曲霉毒素在实施例2中线性回归方程、线性相关系数r、检测限及定量限。Table 3 Linear regression equation, linear correlation coefficient r, detection limit and quantification limit of aflatoxin in Example 2.
注:检测限及定量限限度=相应对照品溶液浓度/样品浓度Note: detection limit and quantitative limit = corresponding reference substance solution concentration/sample concentration
1,4-丁二磺酸腺苷蛋氨酸原料药中黄曲霉毒素检测:Detection of aflatoxin in 1,4-butanedisulfonic acid adenosylmethionine API:
1,4-丁二磺酸腺苷蛋氨酸样品溶液:称取1,4-丁二磺酸腺苷蛋氨酸样品48mg于15mL离心管中,加入1.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在1,4-丁二磺酸腺苷蛋氨酸样品溶液中均未检出,即小于检测限限度(0.0375μg/kg)。1,4-butanedisulfonic acid adenosylmethionine sample solution: Weigh 48mg of 1,4-butanedisulfonic acid adenosylmethionine sample into a 15mL centrifuge tube, add 1.0mL water for ultrasonic dissolution for 5min, then add 2.0mL dichloromethane , mix well, let it stand for 2min, discard the upper layer solution, pipette 1.0mL of the lower layer solution into the injection vial, blow dry with nitrogen, then add 1.0mL diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxin was not detected in the 1,4-butanedisulfonic acid adenosylmethionine sample solution, which was less than the detection limit (0.0375 μg/kg).
表4黄曲霉毒素在实施例2样品1,4-丁二磺酸腺苷蛋氨酸中准确度Table 4 Aflatoxin Accuracy in Example 2 Sample 1,4-Ademetionine Butanedisulfonate
L-赖氨酸原料药中黄曲霉毒素检测:Detection of aflatoxins in L-lysine raw materials:
L-赖氨酸样品溶液:称取L-赖氨酸样品30mg于15mL离心管中,加入1.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在L-赖氨酸样品溶液中均未检出,即小于检测限限度(0.06μg/kg)。L-lysine sample solution: Weigh 30mg of L-lysine sample into a 15mL centrifuge tube, add 1.0mL water to ultrasonically dissolve for 5min, then add 2.0mL dichloromethane, mix well, let stand for 2min, discard the upper solution , Pipette 1.0mL of the lower layer solution into the sample injection vial, dry it with nitrogen, then add 1.0mL of diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxins were not detected in the L-lysine sample solution, which was less than the detection limit (0.06 μg/kg).
表5黄曲霉毒素在实施例2样品L-赖氨酸中准确度Table 5 aflatoxin accuracy in embodiment 2 sample L-lysine
谷胱甘肽原料药中黄曲霉毒素检测:Detection of aflatoxins in glutathione raw materials:
谷胱甘肽样品溶液:称取L-赖氨酸样品60mg于15mL离心管中,加入1.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在谷胱甘肽样品溶液中均未检出,即小于检测限限度(0.03μg/kg)。Glutathione sample solution: Weigh 60 mg of L-lysine sample into a 15 mL centrifuge tube, add 1.0 mL of water for ultrasonic dissolution for 5 min, then add 2.0 mL of dichloromethane, mix well, let stand for 2 min, discard the upper layer solution, Pipette 1.0mL of the lower layer solution into the sample injection vial, dry it with nitrogen, then add 1.0mL diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxins were not detected in the glutathione sample solution, which was less than the detection limit (0.03 μg/kg).
表6黄曲霉毒素在实施例2样品谷胱甘肽准确度Table 6 aflatoxin accuracy in embodiment 2 sample glutathione
实施例3:Example 3:
仪器:安捷伦超高效液相-三重四级杆质谱联用仪(Agilent 1290-6470)Instrument: Agilent UPLC-triple quadrupole mass spectrometer (Agilent 1290-6470)
流速:0.3mL/minFlow rate: 0.3mL/min
柱温:40℃Column temperature: 40°C
进样量:10.0μLInjection volume: 10.0μL
流动相A:10mM甲酸铵水溶液(称取质谱级甲酸铵0.32g,用500mL超纯水溶解)Mobile phase A: 10mM ammonium formate aqueous solution (weigh 0.32g of mass spectrometry grade ammonium formate and dissolve in 500mL ultrapure water)
流动相B:甲醇Mobile Phase B: Methanol
稀释剂:30%甲醇水溶液(V/V)Diluent: 30% aqueous methanol (V/V)
洗针溶液:80%甲醇水溶液(V/V)Needle washing solution: 80% methanol water solution (V/V)
空白溶剂:同稀释剂Blank solvent: same as diluent
梯度:gradient:
时间(min)time (min) | 流动相A%Mobile phase A% | 流动相B%Mobile phase B% |
0.00.0 | 7070 | 3030 |
3.03.0 | 2020 | 8080 |
5.05.0 | 2020 | 8080 |
5.15.1 | 7070 | 3030 |
7.07.0 | 7070 | 3030 |
质谱条件:Mass Spectrometry Conditions:
黄曲霉毒素对照品标准溶液配制:精密移取适量黄曲霉毒素对照品溶液,逐级 稀释配制含有黄曲霉毒素浓度分别为30ng/L、60ng/L、120ng/L、150ng/L、250ng/L的溶液,作为标准曲线测定液。Preparation of aflatoxin reference standard solution: Precisely pipette an appropriate amount of aflatoxin reference solution, and dilute it step by step to prepare aflatoxin concentrations of 30ng/L, 60ng/L, 120ng/L, 150ng/L, and 250ng/L The solution was used as the standard curve measurement solution.
所述实施例3中四种黄曲霉毒素的线性回归方程及线性相关系数r见表7,方程中y即为相应黄曲霉毒素的峰面积,x即为相应黄曲霉毒素的质量浓度。The linear regression equations and linear correlation coefficients r of the four aflatoxins in Example 3 are shown in Table 7. In the equation, y is the peak area of the corresponding aflatoxin, and x is the mass concentration of the corresponding aflatoxin.
表7黄曲霉毒素在实施例3中线性回归方程、线性相关系数r、检测限及定量限。Table 7 Linear regression equation, linear correlation coefficient r, detection limit and quantification limit of aflatoxin in Example 3.
注:检测限及定量限限度=相应对照品溶液浓度/样品浓度Note: detection limit and quantitative limit = corresponding reference substance solution concentration/sample concentration
1,4-丁二磺酸腺苷蛋氨酸原料药中黄曲霉毒素检测:Detection of aflatoxin in 1,4-butanedisulfonic acid adenosylmethionine API:
1,4-丁二磺酸腺苷蛋氨酸样品溶液:称取1,4-丁二磺酸腺苷蛋氨酸样品600mg于15mL离心管中,加入1.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在1,4-丁二磺酸腺苷蛋氨酸样品溶液中均未检出,即小于检测限限度(0.03μg/kg)。1,4-butanedisulfonic acid adenosylmethionine sample solution: Weigh 600mg of 1,4-butanedisulfonic acid adenosylmethionine sample into a 15mL centrifuge tube, add 1.0mL water for ultrasonic dissolution for 5min, then add 2.0mL dichloromethane , mix well, let it stand for 2min, discard the upper layer solution, pipette 1.0mL of the lower layer solution into the injection vial, blow dry with nitrogen, then add 1.0mL diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxin was not detected in the 1,4-butanedisulfonic acid adenosylmethionine sample solution, which was less than the detection limit (0.03 μg/kg).
表8黄曲霉毒素在实施例3样品1,4-丁二磺酸腺苷蛋氨酸中准确度Table 8 Aflatoxin Accuracy in Example 3 Sample 1,4-Ademetionine Butanedisulfonate
L-赖氨酸原料药中黄曲霉毒素检测:Detection of aflatoxins in L-lysine raw materials:
L-赖氨酸样品溶液:称取L-赖氨酸样品300mg于15mL离心管中,加入1.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在L-赖氨酸样品溶液中均未检出,即小于检测限限度(0.06μg/kg)。L-lysine sample solution: Weigh 300mg of L-lysine sample into a 15mL centrifuge tube, add 1.0mL water for ultrasonic dissolution for 5min, then add 2.0mL dichloromethane, mix well, let stand for 2min, discard the upper solution , Pipette 1.0mL of the lower layer solution into the sample injection vial, dry it with nitrogen, then add 1.0mL of diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxins were not detected in the L-lysine sample solution, which was less than the detection limit (0.06 μg/kg).
表9黄曲霉毒素在实施例3样品L-赖氨酸中准确度Accuracy of table 9 aflatoxin in embodiment 3 sample L-lysine
谷胱甘肽原料药中黄曲霉毒素检测:Detection of aflatoxins in glutathione raw materials:
谷胱甘肽样品溶液:称取L-赖氨酸样品1000mg于15mL离心管中,加入5.0mL水超声溶解5min,再加入2.0mL二氯甲烷,混匀,静置2min,弃去上层溶液,移取下层溶液1.0mL于进样小瓶中,氮气吹干,再加入1.0mL稀释剂溶解,摇匀,作为供试品溶液。用上述液质联用方法进行检测,并用标准曲线法计算样品中黄曲霉毒素的含量。黄曲霉毒素在谷胱甘肽样品溶液中均未检出,即小于检测限限度(0.018μg/kg)。Glutathione sample solution: Weigh 1000mg of L-lysine sample into a 15mL centrifuge tube, add 5.0mL water for ultrasonic dissolution for 5min, then add 2.0mL dichloromethane, mix well, let stand for 2min, discard the upper layer solution, Pipette 1.0mL of the lower layer solution into the sample injection vial, dry it with nitrogen, then add 1.0mL diluent to dissolve, shake well, and use it as the test solution. The above-mentioned LC-MS method was used for detection, and the standard curve method was used to calculate the content of aflatoxin in the sample. Aflatoxins were not detected in the glutathione sample solution, which was less than the detection limit (0.018 μg/kg).
表10黄曲霉毒素在实施例3样品谷胱甘肽中准确度Accuracy of table 10 aflatoxin in embodiment 3 sample glutathione
由上述各实施例可以看出,本发明提供的检测方法,样品前处理简单,采用样品溶解萃取方式解决了样品基质干扰目标峰测定及样品在仪器中残留引起仪器污染;分离度好,黄曲霉毒素与样品在7min实现全部有效分离;线性相关系数好,黄曲霉毒素在3ng/L~25ng/L或30ng/L~250ng/L线性范围内线性相关系数r均>0.99;灵敏度高,黄曲霉毒素仪器检测最低定量限为3ng/L,最低限度为0.1μg/kg,最低检测限为1ng/L,最低限度为0.03μg/kg;回收率高,黄曲霉毒素样品加标准确度回收率均在80%~120%。本方法与现有黄曲霉毒素测定方法对比具有快速、高效、灵敏度高、样品检测无基质干扰,耐用性好等特点,可适用于水溶性药物中黄曲霉毒素定量及定性检测。As can be seen from the above-mentioned embodiments, the detection method provided by the present invention has simple sample pretreatment, and adopts the sample dissolution and extraction method to solve the problem of sample matrix interference target peak measurement and sample residue in the instrument causing instrument pollution; the separation is good, and Aspergillus flavus The toxin and the sample can be effectively separated within 7 minutes; the linear correlation coefficient is good, and the linear correlation coefficient r of aflatoxin in the linear range of 3ng/L-25ng/L or 30ng/L-250ng/L is greater than 0.99; the sensitivity is high, and the aflatoxin The minimum quantification limit for toxin instrument detection is 3ng/L, the minimum limit is 0.1μg/kg, the minimum detection limit is 1ng/L, and the minimum limit is 0.03μg/kg; Between 80% and 120%. Compared with the existing aflatoxin determination method, the method has the characteristics of rapidity, high efficiency, high sensitivity, no matrix interference in sample detection, good durability, etc., and can be applied to the quantitative and qualitative detection of aflatoxin in water-soluble drugs.
Claims (7)
- 一种检测水溶性发酵药物中微量黄曲霉毒素的方法,所述黄曲霉毒素包括黄曲霉毒素B1、黄曲霉毒素B2、黄曲霉毒素G1、黄曲霉毒素G2,其特征在于,所述方法包括:A method for detecting trace amounts of aflatoxin in water-soluble fermented medicines, said aflatoxin comprising aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, characterized in that said method comprises:步骤1:样品用水溶解后,用二氯甲烷萃取得萃取液,萃取液用氮气吹干,再用30%甲醇水溶液(V/V)溶解获得供试品溶液;Step 1: After dissolving the sample in water, extract it with dichloromethane to obtain the extract, dry the extract with nitrogen, and then dissolve it with 30% aqueous methanol (V/V) to obtain the test solution;步骤2:采用超高效液相色谱-质谱联用仪对步骤1的供试品溶液进行检测;Step 2: using ultra-high performance liquid chromatography-mass spectrometry to detect the test solution in step 1;其中,步骤2所述超高效液相色谱的色谱条件为:Wherein, the chromatographic condition of the ultra-high performance liquid chromatography described in step 2 is:色谱柱:十八烷基硅烷键合硅胶色谱柱;Chromatographic column: octadecylsilane bonded silica gel column;流动相:流动相A为10mM甲酸铵水溶液,流动相B为甲醇;流动相的梯度洗脱方式为梯度洗脱,所述梯度洗脱的程序如下表:Mobile phase: Mobile phase A is 10mM ammonium formate aqueous solution, and mobile phase B is methanol; The gradient elution mode of mobile phase is gradient elution, and the program of described gradient elution is as follows:
时间(min)time (min) 流动相A%Mobile phase A% 流动相B%Mobile phase B% 0.00.0 7070 3030 3.03.0 2020 8080 5.05.0 2020 8080 5.15.1 7070 3030 7.07.0 7070 3030 步骤2中所述超高效液相色谱-质谱联用仪为:超高效液相色谱-三重四级杆质谱联用仪;The ultra-high performance liquid chromatography-mass spectrometer described in step 2 is: ultra-high performance liquid chromatography-triple quadrupole mass spectrometry;所述水溶性发酵药物选自阿卡波糖、1,4-丁二磺酸腺苷蛋氨酸、L-赖氨酸和谷胱甘肽。The water-soluble fermented medicine is selected from acarbose, 1,4-butanedisulfonic acid ademetionine, L-lysine and glutathione. - 如权利要求1所述的方法,其特征在于,步骤1中,所述样品用水溶解后,配置成1mL中溶解1~1000mg、优选为1~800mg、更优选1~700mg、最优选10~500mg的样品溶液;加入二氯甲烷2mL,混匀,静置后弃去上层溶液,移取下层溶液1mL,氮气吹干,直接用30%甲醇水溶液(V/V)溶解,获得供试品溶液。The method according to claim 1, characterized in that in step 1, after the sample is dissolved in water, it is configured to dissolve 1-1000 mg, preferably 1-800 mg, more preferably 1-700 mg, most preferably 10-500 mg in 1 mL. Add 2 mL of dichloromethane, mix well, discard the upper layer solution after standing, pipette the lower layer solution 1 mL, blow dry with nitrogen, and directly dissolve with 30% aqueous methanol (V/V) to obtain the test solution.
- 如权利要求1-2任一项所述的方法,其特征在于,步骤2中所述十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~4.6mm、柱长为50mm~150mm、粒径为 1.6μm~3.5μm;优选十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~3.5mm、柱长为50mm~100mm、粒径为1.6μm~2.5μm;更优选十八烷基硅烷键合硅胶色谱柱的柱径为2.1mm~3.0mm、柱长为50mm~100mm、粒径为1.6μm~1.8μm;最优选Waters C18色谱柱,柱径为2.1mm、柱长为100mm、粒径为1.6μm。 The method according to any one of claims 1-2, wherein the column diameter of the octadecylsilane-bonded silica gel chromatographic column described in step 2 is 2.1 mm to 4.6 mm, and the column length is 50 mm to 150 mm. The particle size is 1.6 μm to 3.5 μm; preferably, the octadecylsilane bonded silica gel column has a column diameter of 2.1 mm to 3.5 mm, a column length of 50 mm to 100 mm, and a particle size of 1.6 μm to 2.5 μm; more preferably octadecylsilane The column diameter of the alkylsilane bonded silica gel column is 2.1mm-3.0mm, the column length is 50mm-100mm, and the particle size is 1.6μm-1.8μm; the most preferred Waters C18 chromatographic column, the column diameter is 2.1mm, the column length is 100mm, and the particle size is 1.6μm.
- 如权利要求1-3任一项所述的方法,其特征在于,步骤2中所述色谱柱的柱温为25℃~45℃,优选30℃~45℃,更优选35℃~40℃,最优选40℃。The method according to any one of claims 1-3, characterized in that the column temperature of the chromatographic column in step 2 is 25°C to 45°C, preferably 30°C to 45°C, more preferably 35°C to 40°C, 40°C is most preferred.
- 如权利要求1-4任一项所述的方法,其特征在于,步骤2中所述流动相的流速为0.2mL/min~0.6mL/min,优选0.3mL/min~0.5mL/min,更优选0.3mL/min~0.4mL/min,最优选0.3mL/min。The method according to any one of claims 1-4, wherein the flow rate of the mobile phase in step 2 is 0.2mL/min~0.6mL/min, preferably 0.3mL/min~0.5mL/min, more preferably Preferably 0.3mL/min~0.4mL/min, most preferably 0.3mL/min.
- 如权利要求1-5任一项所述的方法,其特征在于,步骤2中所述质谱的参数为:The method according to any one of claims 1-5, wherein the parameters of the mass spectrum in step 2 are:扫描模式:质谱多反应监测;Scan mode: mass spectrometry multiple reaction monitoring;离子源:电喷雾离子源;Ion source: electrospray ion source;离子源模式:正模式;Ion source mode: positive mode;毛细管电压:0.3~1.0KV,优选0.4~0.8KV,更优选0.5KV;Capillary voltage: 0.3-1.0KV, preferably 0.4-0.8KV, more preferably 0.5KV;干燥气温度:300~650℃,优选450~600℃,更优选550℃;Drying gas temperature: 300-650°C, preferably 450-600°C, more preferably 550°C;干燥气流速:1000L/Hr;Drying gas flow rate: 1000L/Hr;锥孔电压:15~40V,优选20~30V,更优选35V;Cone voltage: 15-40V, preferably 20-30V, more preferably 35V;源温:150℃。Source temperature: 150°C.
- 如权利要求1-6任一项所述的方法,其特征在于,步骤2中所述超高效液相色谱-质谱联用仪为Waters ACQUITY I PLUS\XEVO TQ-XS、Waters ACQUITY I UPLC Class-TQ-S micro、Agilent 1290-6470,优选Waters ACQUITY I PLUS\XEVO TQ-XS。 The method according to any one of claims 1-6, wherein the ultra-high performance liquid chromatography-mass spectrometer described in step 2 is Waters ACQUITY I PLUS\XEVO TQ-XS, Waters ACQUITY I UPLC Class-TQ-S micro, Agilent 1290-6470, preferably Waters ACQUITY I PLUS\XEVO TQ-XS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110658505.7 | 2021-06-15 | ||
CN202110658505.7A CN113390992B (en) | 2021-06-15 | 2021-06-15 | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022262245A1 true WO2022262245A1 (en) | 2022-12-22 |
Family
ID=77620958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/141051 WO2022262245A1 (en) | 2021-06-15 | 2021-12-24 | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicament |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113390992B (en) |
WO (1) | WO2022262245A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116399984A (en) * | 2023-06-09 | 2023-07-07 | 天津辰欣药物研究有限公司 | Method for measuring residual quantity of tetrabutylammonium iodide in WXTJ0262 bulk drug by utilizing liquid phase-mass spectrum combined method |
CN117554532A (en) * | 2024-01-10 | 2024-02-13 | 未名环境分子诊断(常熟)有限公司 | Sibutramine detection method |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113390992B (en) * | 2021-06-15 | 2023-05-12 | 浙江海正药业股份有限公司 | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicine |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4285698A (en) * | 1980-04-28 | 1981-08-25 | Peanut Research & Testing Laboratories, Inc. | Analysis of aflatoxins in peanuts by high pressure liquid chromatograph |
CN107907600A (en) * | 2017-10-25 | 2018-04-13 | 大连理工大学 | It is a kind of that the method for aflatoxin and flavouring agent in vegetable fat is measured based on liquid-liquid extraction Liquid Chromatography-Tandem Mass Spectrometry at the same time |
US20180120327A1 (en) * | 2015-03-12 | 2018-05-03 | Mars, Incorporated | Ultra high resolution mass spectrometry and methods of using the same |
CN110609107A (en) * | 2019-09-16 | 2019-12-24 | 宁波立华制药有限公司 | Method for detecting aflatoxins G2, G1, B2 and B1 in radix paeoniae alba decoction pieces by using ultra-high performance liquid chromatography-mass spectrometry |
CN112147240A (en) * | 2019-06-28 | 2020-12-29 | 泰州医药城国科化物生物医药科技有限公司 | Extraction and detection method of aflatoxin in spina date seeds |
CN112198242A (en) * | 2020-09-10 | 2021-01-08 | 杭州汉库医药科技有限公司 | Method for determining aflatoxins B1, B2, G1 and G2 in angelica sinensis by ultra-high performance liquid chromatography-mass spectrometry |
CN113390992A (en) * | 2021-06-15 | 2021-09-14 | 浙江海正药业股份有限公司 | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20050905A1 (en) * | 2005-12-23 | 2007-06-24 | Univ Degli Studi Torino | SYNTHETIC BINDERS THAT CAN TIE THE OCRATOSSIN AND ITS USES |
CN102338789A (en) * | 2011-04-22 | 2012-02-01 | 上海谱尼测试技术有限公司 | Fast instrumental analysis method for aflatoxins in foods |
CN106770789B (en) * | 2017-01-16 | 2020-04-10 | 东北农业大学 | Ultra-high performance liquid chromatography method for simultaneously detecting contents of aflatoxin B1 and M1 in liver, kidney and chicken of broiler chicken |
CN109839464B (en) * | 2017-11-24 | 2021-09-28 | 中国科学院大连化学物理研究所 | Pretreatment method for detecting aflatoxin in food matrix |
CN108760929A (en) * | 2018-06-13 | 2018-11-06 | 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所) | A method of detection 8 kinds of mycotoxins of FRUCTUS CITRI SARCODACTYLIS |
CN112067710A (en) * | 2020-08-11 | 2020-12-11 | 吉林省农业科学院 | Method for detecting various biotoxins in grain and oil crops |
-
2021
- 2021-06-15 CN CN202110658505.7A patent/CN113390992B/en active Active
- 2021-12-24 WO PCT/CN2021/141051 patent/WO2022262245A1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4285698A (en) * | 1980-04-28 | 1981-08-25 | Peanut Research & Testing Laboratories, Inc. | Analysis of aflatoxins in peanuts by high pressure liquid chromatograph |
US20180120327A1 (en) * | 2015-03-12 | 2018-05-03 | Mars, Incorporated | Ultra high resolution mass spectrometry and methods of using the same |
CN107907600A (en) * | 2017-10-25 | 2018-04-13 | 大连理工大学 | It is a kind of that the method for aflatoxin and flavouring agent in vegetable fat is measured based on liquid-liquid extraction Liquid Chromatography-Tandem Mass Spectrometry at the same time |
CN112147240A (en) * | 2019-06-28 | 2020-12-29 | 泰州医药城国科化物生物医药科技有限公司 | Extraction and detection method of aflatoxin in spina date seeds |
CN110609107A (en) * | 2019-09-16 | 2019-12-24 | 宁波立华制药有限公司 | Method for detecting aflatoxins G2, G1, B2 and B1 in radix paeoniae alba decoction pieces by using ultra-high performance liquid chromatography-mass spectrometry |
CN112198242A (en) * | 2020-09-10 | 2021-01-08 | 杭州汉库医药科技有限公司 | Method for determining aflatoxins B1, B2, G1 and G2 in angelica sinensis by ultra-high performance liquid chromatography-mass spectrometry |
CN113390992A (en) * | 2021-06-15 | 2021-09-14 | 浙江海正药业股份有限公司 | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicine |
Non-Patent Citations (1)
Title |
---|
TIAN ER-NUO; !, DU XIN; CAI JUN: "Determination of Aflatoxin B1 in Corn Syrup by Organic Solvent Extraction and High Performance Liquid Chromatography", SCIENCE AND TECHNOLOGY OF FOOD INDUSTRY, GAI KAN BIANJIBU , BEIJING, CN, vol. 39, no. 23, 31 December 2018 (2018-12-31), CN , pages 267 - 271, XP093015200, ISSN: 1002-0306, DOI: 10.13386/j.issn1002-0306.2018.23.046 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116399984A (en) * | 2023-06-09 | 2023-07-07 | 天津辰欣药物研究有限公司 | Method for measuring residual quantity of tetrabutylammonium iodide in WXTJ0262 bulk drug by utilizing liquid phase-mass spectrum combined method |
CN116399984B (en) * | 2023-06-09 | 2023-08-15 | 天津辰欣药物研究有限公司 | Method for measuring residual quantity of tetrabutylammonium iodide in WXTJ0262 bulk drug by utilizing liquid phase-mass spectrum combined method |
CN117554532A (en) * | 2024-01-10 | 2024-02-13 | 未名环境分子诊断(常熟)有限公司 | Sibutramine detection method |
CN117554532B (en) * | 2024-01-10 | 2024-04-16 | 未名环境分子诊断(常熟)有限公司 | Sibutramine detection method |
Also Published As
Publication number | Publication date |
---|---|
CN113390992A (en) | 2021-09-14 |
CN113390992B (en) | 2023-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022262245A1 (en) | Method for analyzing and detecting trace aflatoxin in water-soluble fermented medicament | |
Tan et al. | Determination of aflatoxins in food using liquid chromatography coupled with electrospray ionization quadrupole time of flight mass spectrometry (LC-ESI-QTOF-MS/MS) | |
WO2016090730A1 (en) | Method for determining content of impurities in lapatinib by using lc-ms/ms | |
Bodur et al. | Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS | |
Chimalakonda et al. | Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release | |
Yousefi‐Taemeh et al. | Analysis of tetrahydrocannabinol derivative from cannabis‐infused chocolate by QuEChERS‐thin layer chromatography‐desorption electrospray ionization mass spectrometry | |
CN110286178B (en) | High-throughput analysis method for detecting 22 mycotoxins in health food oral liquid | |
KR100848132B1 (en) | Simultaneous determination of amphetamine-type stimulants and cannabinoids by gas chromatography | |
CN108445128B (en) | Method for measuring residual amount of carbamate drugs in eggs | |
CN111579683A (en) | Kit for detecting antiatherosclerotic drugs in plasma by ultra-performance liquid chromatography tandem mass spectrometry | |
Xun et al. | Simultaneous determination of seven acrylates in food contact paper products by GC/MS and modified QuEChERS | |
Ramesh et al. | LC–HRMS determination of piperine on rat dried blood spots: A pharmacokinetic study | |
Semwal et al. | Impact of UPLC-MS in food and drug/metabolite analysis | |
Tzing et al. | On-line derivatization gas chromatography with furan chemical ionization tandem mass spectrometry for screening of amphetamines in urine | |
CN114577950A (en) | Method for determining anti-infective drugs in cosmetics | |
CN111198235B (en) | Method for detecting content of isosinensetin in plasma | |
Song et al. | Quantitative determination of fluconazole by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) in human plasma and its application to a pharmacokinetic study | |
CN114280206A (en) | Method for detecting mycotoxin in spice and product thereof | |
WO2020258710A1 (en) | Method for extracting and detecting aflatoxin in semen ziziphi spinosae | |
CN113820424A (en) | HPLC-MS/MS method for simultaneously determining concentration of 14 antidepressants in human plasma | |
Hong et al. | Simultaneous determination of residual stilbenes and stilbene metabolites in animal tissue by liquid chromatography–tandem mass spectrometry | |
CN108535400B (en) | Thin-layer chromatography analysis and detection method for impurity 5-methoxytryptamine in melatonin bulk drug | |
CN114924003B (en) | Method for detecting fluorouracil content in fluorouracil oral milk | |
KR100709555B1 (en) | Method for the determination of anti HIV drugs in plasma with high performance liquid chromatography-mass spectrometry | |
CN106248825B (en) | Starting material A detection method in hydrochloride landiolol material medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21945821 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |